HK1046846A1 - Anti-tumor agents comprising boroproline compounds - Google Patents

Anti-tumor agents comprising boroproline compounds

Info

Publication number
HK1046846A1
HK1046846A1 HK02106843.4A HK02106843A HK1046846A1 HK 1046846 A1 HK1046846 A1 HK 1046846A1 HK 02106843 A HK02106843 A HK 02106843A HK 1046846 A1 HK1046846 A1 HK 1046846A1
Authority
HK
Hong Kong
Prior art keywords
tumor agents
boroproline compounds
boroproline
compounds
tumor
Prior art date
Application number
HK02106843.4A
Other languages
Chinese (zh)
Inventor
P Wallner Barbara
Miller Glenn
Original Assignee
Point Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Point Therapeutics Inc filed Critical Point Therapeutics Inc
Publication of HK1046846A1 publication Critical patent/HK1046846A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02106843.4A 1999-05-25 2002-09-19 Anti-tumor agents comprising boroproline compounds HK1046846A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13586199P 1999-05-25 1999-05-25
PCT/US2000/014505 WO2000071135A1 (en) 1999-05-25 2000-05-25 Anti-tumor comprising boroproline compounds

Publications (1)

Publication Number Publication Date
HK1046846A1 true HK1046846A1 (en) 2003-01-30

Family

ID=22470056

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106843.4A HK1046846A1 (en) 1999-05-25 2002-09-19 Anti-tumor agents comprising boroproline compounds

Country Status (6)

Country Link
EP (1) EP1187619A1 (en)
JP (1) JP2003500360A (en)
AU (1) AU781897B2 (en)
CA (1) CA2373643A1 (en)
HK (1) HK1046846A1 (en)
WO (1) WO2000071135A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
UA76718C2 (en) 2000-06-30 2006-09-15 Фарма Мар, С.А. Anticancer aplidine derivatives
CN1479622A (en) 2000-10-12 2004-03-03 Treatment of cancers by aplidine in conjunction with myoprotector
WO2003037373A1 (en) * 2001-10-31 2003-05-08 Medical Research Council Use of an ep2 or ep4 receptor antagonist and/or a cox-1 inhibitor for treating cervical cancer
EP1469873A4 (en) * 2001-11-26 2007-10-03 Tufts College Peptidomimetic inhibitors of post-proline cleaving enzymes
JP2003267966A (en) * 2002-03-13 2003-09-25 Pola Chem Ind Inc Flavan derivative, skin fibroblast proliferation inhibitor and external preparation for skin
EP1578434A2 (en) * 2002-07-09 2005-09-28 Point Therapeutics, Inc. Methods and compositions relating to isoleucine boroproline compounds
AU2004218883B2 (en) 2003-03-12 2009-10-01 Dana-Farber Cancer Institute, Inc. Aplidine for multiple myeloma treatment
US7699057B2 (en) * 2003-03-13 2010-04-20 3M Innovative Properties Company Methods for treating skin lesions
DOP2006000008A (en) 2005-01-10 2006-08-31 Arena Pharm Inc COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
PE20071221A1 (en) 2006-04-11 2007-12-14 Arena Pharm Inc GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
US8835506B2 (en) 2008-06-05 2014-09-16 Stc.Unm Methods and related compositions for the treatment of cancer
AR077642A1 (en) 2009-07-09 2011-09-14 Arena Pharm Inc METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
EP2556056A1 (en) 2010-04-06 2013-02-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
KR101871011B1 (en) 2010-09-22 2018-06-25 아레나 파마슈티칼스, 인크. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145604A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US9284337B2 (en) 2011-11-22 2016-03-15 Trustees Of Tufts College Small molecule enhancer for dendritic cell cancer vaccines
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
EA201791982A1 (en) 2015-03-09 2020-02-17 Интекрин Терапьютикс, Инк. METHODS FOR TREATING A NON-ALCOHOLIC FAT LIVER DISEASE AND / OR LIPODYSTROPHY
US20200030411A1 (en) * 2016-09-21 2020-01-30 Agency For Science, Technology And Research Methods and Compositions for Inhibiting Skin Inflammation and Determining Cancer Susceptibility
CN110996951A (en) 2017-04-03 2020-04-10 科赫罗斯生物科学股份有限公司 PPAR gamma agonists for the treatment of progressive supranuclear palsy
CN115779148B (en) * 2021-09-09 2024-02-23 中国科学院福建物质结构研究所 Dental implant surface coating and preparation method and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02268118A (en) * 1989-04-07 1990-11-01 Mitsubishi Gas Chem Co Inc Immnunoactivator
US5328936A (en) * 1993-02-01 1994-07-12 Rohm And Haas Company Polymerization process for making porous polymeric particles
IL111785A0 (en) * 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
US5767242A (en) * 1994-04-20 1998-06-16 Boehringer Ingelheim Int'l Gmbh Isolated dimeric fibroblast activation protein alpha, and uses thereof
US5952301A (en) * 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function
US6100234A (en) * 1997-05-07 2000-08-08 Tufts University Treatment of HIV
PT1084129E (en) * 1998-06-05 2003-06-30 Point Therapeutics Inc BOROPROLINE CYCLIC COMPOUNDS
KR20010079669A (en) * 1998-08-21 2001-08-22 바바라 피. 월너 Regulation of Substrate Activity

Also Published As

Publication number Publication date
CA2373643A1 (en) 2000-11-30
AU781897B2 (en) 2005-06-23
JP2003500360A (en) 2003-01-07
AU5292700A (en) 2000-12-12
EP1187619A1 (en) 2002-03-20
WO2000071135A1 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
HK1046846A1 (en) Anti-tumor agents comprising boroproline compounds
IL145798A0 (en) Fap-activated anti-tumor compounds
HUP0202442A3 (en) Multiple cytokine-antibody complexes
GB2357761B (en) Compounds
IL139885A0 (en) Cyclic boroproline compounds
GB9904933D0 (en) Compounds
GB9902399D0 (en) Compounds
GB9908828D0 (en) Compounds
GB9904930D0 (en) Thiazoloindolinone compounds
GB9905771D0 (en) Compounds
GB9927157D0 (en) Releasable Ligand
GB9915342D0 (en) Acaricides
GB9918566D0 (en) Sentinel
GB9912821D0 (en) Compounds
GB9908931D0 (en) Compounds
GB9901425D0 (en) Compounds
GB9901429D0 (en) Compounds
GB9930074D0 (en) Compounds
GB9903239D0 (en) Compounds
GB9903241D0 (en) Compounds
GB9903296D0 (en) Compounds
GB9903243D0 (en) Compounds
GB9903266D0 (en) Compounds
GB9925521D0 (en) Compounds
GB9910711D0 (en) Compounds